GPR30 is highly expressed in breast-cancer-associated fibroblasts [139,140], and GPR30-induced gene activation results in an enrichment of high mobility group box 1 (HMGB1) [132], which induces tamoxifen resistance through the MEK–ERK signaling pathway while increasing autophagic activities. Here, HMGB1 is linked to breast carcinoma.